Home » Newsletters » BioWorld

BioWorld

April 15, 1993

View Archived Issues

DNAP EXPANDS TEST MARKETS FOR ITS VINESWEET TOMATO

EDITEK'S ONE-STEP ASSAY RECEIVES PATENT

IMCLONE GETS LICENSE TO EGFR MABS

SANDOZ SELLS HUMAN MAbs TO PDL FOR $5 MILLION

SANDOZ AND SYSTEMIX TEAM UP FOR AIDS GENE THERAPY

CALGENE WILL LABEL ITS ANTISENSE TOMATO

GREENWICH FILES PLA

LIFECELL GETS SBIR GRANT

CELLTECH TO BUILD MANUFACTURING FACILITY IN N.H.

PPTI GETS PATENT FOR BETASILK

SANDOZ LICENSES BTG'S AMINOPEPTIDASE

ARMY TRANSFERS AIDS TRIAL FUNDS TO DHHS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...